Latest updates, from us and our ventures
Q3 2019
From October 1st to 3rd, we'll be at #HubWeek2019 with our Leaps Underwater Research Lab escape game -… https://t.co/RAFCwJHzJl
— Leaps by Bayer (@LeapsByBayer) September 30, 2019
1 out of 5 suffers from the risk of a heart attack globally according to @worldheartfed. #hearthealth should not be… https://t.co/1mCk3tYqfc
— BlueRock (@BlueRockTx) September 30, 2019
We're pleased to announce that #LeapsTalk II will be taking place at #HubWeek2019 in Boston. We’ll be joined by… https://t.co/eeO9XqOAeL
— Leaps by Bayer (@LeapsByBayer) September 30, 2019
Calling on all great minds and diverse talents in Boston. Join us for #HubWeek2019 to prove your team are up for a… https://t.co/vpEgyBf1cl
— Leaps by Bayer (@LeapsByBayer) September 25, 2019
Do you have what it takes to achieve a #biotech breakthrough? Join us in the spirit of innovation, collaboration an… https://t.co/5mfbsROvCO
— Leaps by Bayer (@LeapsByBayer) September 24, 2019
Scientists at @MIT have used #CRISPRCas12 to create shapeshifting #DNA hydrogels that could enable new, sophisticat… https://t.co/3sfdJPaLRn
— Leaps by Bayer (@LeapsByBayer) September 24, 2019
Do you have what it takes to achieve a #biotech breakthrough? Join us in the spirit of innovation, collaboration an… https://t.co/CJaED4Smj4
— Leaps by Bayer (@LeapsByBayer) September 20, 2019
The remarkable story of how nurse and lecturer @stumpw0rk50 quite literally sniffed out her husband’s… https://t.co/u7oAXef2Qv
— Leaps by Bayer (@LeapsByBayer) September 18, 2019
We’re thrilled to be partnering with @norrsken_org for this year’s #NorrskenImpactWeek. From a list of the top 100… https://t.co/pfbqRSeyW5
— Leaps by Bayer (@LeapsByBayer) September 17, 2019
20 minutes, one crucial specimen and your team. We’re bringing #BreakingThroughImpossible - The Escape game to… https://t.co/W0kxOkMKxf
— Leaps by Bayer (@LeapsByBayer) September 17, 2019
In a similar vein to the work of @JoynBio, young scientist Barkissa Fofana believes that microbiology and an approa… https://t.co/g4IbPYABMq
— Leaps by Bayer (@LeapsByBayer) September 16, 2019
We were proud to join the New England Parkinson's Ride #NEPDride aimed to raise awareness & funds for #Parkinsons r… https://t.co/g6lJt1vl01
— BlueRock (@BlueRockTx) September 12, 2019
RT @FoodBeerScience: Diagnosis by whole genome sequencing is becoming a reality https://t.co/0mj8VFj7AU
— Leaps by Bayer (@LeapsByBayer) September 11, 2019
Japan remains ahead of the curve in the clinical use of iPS cells as ophthalmologist Kohji Nishida, from… https://t.co/EE8WuWupkc
— Leaps by Bayer (@LeapsByBayer) September 11, 2019
Boston’s #biotech leaders know achieving #breakthroughs takes commitment, bravery, and collaboration. That’s why ou… https://t.co/NYYXgCpAFL
— Leaps by Bayer (@LeapsByBayer) September 06, 2019
We can’t wait to launch #BreakingThroughImpossible – the Escape Game in #Boston at #HubWeek2019 https://t.co/pbqS3tDF86
— Leaps by Bayer (@LeapsByBayer) September 05, 2019
We’re thrilled to partner with @HubWeek for this year’s #HubWeek2019 Fall Festival. We’re launching a… https://t.co/ml2onTRScr
— Leaps by Bayer (@LeapsByBayer) September 05, 2019
Beans are amazing. Our colleagues at @JoynBio are working to infuse pulse-plant characteristics into other crops in… https://t.co/Ksfxz5rJ9L
— Leaps by Bayer (@LeapsByBayer) September 04, 2019
RT @JSheltzer: I don't know who needs to hear it, but there is an S. pyogenes Cas9 PAM sequence exactly 4bp downstream of the wild-type all…
— Leaps by Bayer (@LeapsByBayer) September 03, 2019
The use of open data sets in Pharma research could provide insights that can lead to newer and better drugs develop… https://t.co/ZIQMyzj9cf
— Leaps by Bayer (@LeapsByBayer) August 30, 2019
A population of 1.4 billion means huge strain on finite natural resources. How then, with strict limitations on GM… https://t.co/6mqHeBe6HQ
— Leaps by Bayer (@LeapsByBayer) August 29, 2019
A new liquid biopsy called TARDIS could be a game changer in the fight against breast cancer. The new blood test ha… https://t.co/6KO1ZENYmK
— Leaps by Bayer (@LeapsByBayer) August 27, 2019
'It starts to feel a bit like science fiction’. @biodesign_lab and @ricesspb of @riceuniversity are on track to eng… https://t.co/Fdt4UtT5p6
— Leaps by Bayer (@LeapsByBayer) August 26, 2019
#TB to our first ever #Leapstalk at #TOA19. Biotech, Health & the Era of Fast Capital with @ErikaMCheung and… https://t.co/CQ39veoOG6
— Leaps by Bayer (@LeapsByBayer) August 23, 2019
#MyocardialInfarction causes life-threatening damage to the heart. But #stemcell biologist Dr Ban Kiwon, of… https://t.co/WGomxpBXaj
— Leaps by Bayer (@LeapsByBayer) August 22, 2019
Monoclonal antibodies are a mainstay of modern medicine when fighting the likes of lupus and cancer. But how did th… https://t.co/IbSfOHt3hh
— Leaps by Bayer (@LeapsByBayer) August 21, 2019
Russian microbiologist, Denis Rebrikov, wants to follow in He Jianku’s footsteps and do what most scientists and ex… https://t.co/Sy9iJhlgxi
— Leaps by Bayer (@LeapsByBayer) August 12, 2019
The app 'Streams' by @DeepMindAI has provided the first hints that using #AI might be a much better way of assessin… https://t.co/AUKEdSlVn7
— Leaps by Bayer (@LeapsByBayer) August 09, 2019
RT @BayerPharma: The acquisition of @BlueRockTx manifests our successful innovation strategy with @LeapsByBayer to create biotechnological…
— Leaps by Bayer (@LeapsByBayer) August 08, 2019
This just in: With @BlueRockTx‘s industry-leading #iPSCs platform, we are thrilled to continue the journey towards… https://t.co/MzIpTsZuMd
— Leaps by Bayer (@LeapsByBayer) August 08, 2019
RT @BayerPharma: #NEWS: #Bayer will build leading position in cell therapy and acquires @BlueRockTx #CellTherapy #Innovation #StemCells…
— BlueRock (@BlueRockTx) August 08, 2019
We are pleased to announce that one of our founding investors, @BayerPharma, is building a leading position in… https://t.co/nmJVEcaWWB
— BlueRock (@BlueRockTx) August 08, 2019
A momentous occasion as the first study to test #CRISPR technology inside the human body is about to begin in the U… https://t.co/YYZm41GhtF
— Leaps by Bayer (@LeapsByBayer) August 08, 2019
Of 500 Americans involved in a 2-part study about #GMOs, 90% opposed their use. The same people also scored the low… https://t.co/D0u3GRuXXa
— Leaps by Bayer (@LeapsByBayer) August 07, 2019
54% of Americans believe the public should play an important role in guiding policy decisions on scientific issues,… https://t.co/LX1r27kvVX
— Leaps by Bayer (@LeapsByBayer) August 05, 2019
This week our #MissionBay team had a great summer outing and #teambuilding event at @HandsonGourmet in… https://t.co/zI4vasIjbm
— Casebia Therapeutics (@casebiatx) August 02, 2019
Dr. Gordon Keller, received the prestigious #OgawaYamanaka Stem Cell Prize for his work in stem cell biology and re… https://t.co/O33AThDHpK
— BlueRock (@BlueRockTx) August 02, 2019
As part of our “Casebia Coast to Coast Backpack Drive” our Mission Bay and Cambridge teams had the opportunity to f… https://t.co/UkzNzQ5rD9
— Casebia Therapeutics (@casebiatx) August 01, 2019
Our first ever #LeapsTalk features @ErikaMCheung and @SethBannon unpacking some of the ethical issues we're facing… https://t.co/r5LT8jjHLZ
— Leaps by Bayer (@LeapsByBayer) July 31, 2019
In a new effort to expand their research on plant microbes and nitrogen fixation, @joynbio have partnered with… https://t.co/LXR4lKrKOP
— Leaps by Bayer (@LeapsByBayer) July 30, 2019
Swedish researchers led by @EdwinWHJager of @liu_universitet have developed a new fabric that can be knitted and we… https://t.co/wF69CCcgcg
— Leaps by Bayer (@LeapsByBayer) July 26, 2019
While the mini organoids grown by @MCRI_for_kids cannot yet replace kidneys, they’re helping unlock the full potent… https://t.co/lDtKz5CJtr
— Leaps by Bayer (@LeapsByBayer) July 24, 2019
We’re proud to share that @RobinWalker will be speaking on two panels at this week’s @ACI_Pharma's Women Leaders i… https://t.co/whmg1eDtYm
— Casebia Therapeutics (@casebiatx) July 23, 2019
With plans to seek FDA approval to start clinical trials with humans next year, @neuralink claims that millions of… https://t.co/LTTrXfphe9
— Leaps by Bayer (@LeapsByBayer) July 22, 2019
Peter Nell, Ph.D., @CasebiaTx's SVP, Head of Corporate Strategy and Business Development, is featured in this excel… https://t.co/Va1jGmoEfw
— Casebia Therapeutics (@casebiatx) July 19, 2019
We’re backing @PyxisOncology in developing breakthroughs to fight cancer. Pyxis uses new understanding of a tumor's… https://t.co/8CoRHiibM0
— Leaps by Bayer (@LeapsByBayer) July 17, 2019
RT @BosBizJournal: Local biotechs UniQure, Casebia step up race for new hemophilia drugs https://t.co/Gao2CSVaQ8 https://t.co/zVu928WWHm
— Casebia Therapeutics (@casebiatx) July 12, 2019
Senior Scientist Keith Abe from our #MissionBay office will be speaking next week at the @ACDbio Symposium in… https://t.co/toNwz5bRVZ
— Casebia Therapeutics (@casebiatx) July 12, 2019
Of those included in genome-wide association studies of 2018, only 10% were Asian, 2% African, 1% Hispanic and less… https://t.co/X5PcMHsHfK
— Leaps by Bayer (@LeapsByBayer) July 12, 2019
Next week on July 16th, our SVP and Head of Technical Operations Stephen Kennedy will be speaking on the topic of '… https://t.co/RP7b7Jla68
— Casebia Therapeutics (@casebiatx) July 11, 2019
Did you know cells can talk to each other? Now, scientists can record them communicating in real time, allowing for… https://t.co/xD22gfQCPu
— Leaps by Bayer (@LeapsByBayer) July 10, 2019
A successful @ISTH 2019 Congress including a presentation by @CasebiaTx Principal Scientist Alan Brooks on 'Therape… https://t.co/P212PGTnhj
— Casebia Therapeutics (@casebiatx) July 08, 2019
Breaking news: @CasebiaTx highlights novel #research in #geneediting therapeutics for #hemophiliaA; early-stage ani… https://t.co/dY0fbDqOyJ
— Casebia Therapeutics (@casebiatx) July 08, 2019
Researchers at the @templemedschool and @unmc have pooled together in a groundbreaking collaboration to successfull… https://t.co/WINSxfQEXT
— Leaps by Bayer (@LeapsByBayer) July 08, 2019
'There are 17,100,000 deaths from cardiovascular disease each year in the USA. That's 300 people gone since I start… https://t.co/Mo9FcXftQ2
— Leaps by Bayer (@LeapsByBayer) July 05, 2019
The first #LeapsTalk featured Theranos whistleblower and molecular biologist @ErikaMCheung. Erika is the co-founder… https://t.co/yKbnAak6FZ
— Leaps by Bayer (@LeapsByBayer) July 05, 2019
Head of Leaps by Bayer, Jürgen Eckhardt, kicking off the first ever #LeapsTalk yesterday with @ErikaMCheung,… https://t.co/XSbjAeEjV5
— Leaps by Bayer (@LeapsByBayer) July 05, 2019
Our first ever #LeapsTalk takes place @TOABerlin: Biotech, Health & the Era of Fast Capital. We explore what we can… https://t.co/xtfcBOLUFT
— Leaps by Bayer (@LeapsByBayer) July 04, 2019
#HappyFourth from all of us at Casebia! https://t.co/gYDG6M1OSr
— Casebia Therapeutics (@casebiatx) July 03, 2019
We’re partnering with @century_tx to develop curative therapies for cancer using #iPSCs. Learn more here:… https://t.co/EoXlohsNeL
— Leaps by Bayer (@LeapsByBayer) July 01, 2019